Back to Compound Explorer

Ergosterol

Preliminary

Mechanism of Action

Ergosterol inhibits tumor-induced neovascularization by blocking the angiogenic response required for solid tumor growth beyond 1-2 mm diameter. It disrupts vascular endothelial growth factor (VEGF) signaling pathways without exhibiting direct cytotoxicity to tumor cells in vitro, making it an indirect anti-tumor compound with minimal off-target cellular damage. Upon UV exposure, ergosterol converts to vitamin D2 (ergocalciferol), contributing additional immunomodulatory effects through vitamin D receptor (VDR) signaling.

Research Notes

In vivo studies in Lewis lung carcinoma models demonstrated significant reduction of pulmonary metastatic nodule formation following oral ergosterol supplementation. Anti-angiogenic activity was confirmed in subcutaneous tumor implant models where ergosterol reduced microvessel density surrounding tumors. No direct in vitro cytotoxicity was observed, confirming the anti-angiogenic rather than cytotoxic mechanism.

Found In 1 Herb

3D Molecular Structure

Steroid (provitamin D2)
Drag to rotate · Click atoms to explore

Ergosterol

Steroid (provitamin D2)Lipid-based molecules that regulate physiological processes

Representative pattern: C₂₁H₃₀O₂

Atoms
Carbon
Oxygen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.